EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluating operational parameters of the careHPV, GeneXpert, AmpFire, and MA-6000 HPV systems for cervical precancer screening: Experience from Battor, Ghana

Kofi Effah iD, Comfort Mawusi Wormenor, Ethel Tekpor, Joseph Emmanuel Amuah, Nana Owusu M Essel iD, Isaac Gedzah, Seyram Kemawor iD, Benjamin Tetteh Hansen, Bernard Hayford Atuguba, Gifty Belinda Klutsey, Edna Sesenu, Stephen Danyo und 1 weitere

PLOS Global Public Health · 25.08.2023 · 3 (8) · e0001639

DOI: 10.1371/journal.pgph.0001639 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Global Public Health, online erschienen am 25.08.2023. Verfasst von Kofi Effah und 12 weiteren Autor:innen. Beteiligte Einrichtung: Catholic Hospital, Battor, via Sogakope, Volta Region, Ghana. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In response to calls by the World Health Organization for cervical precancer screening services in low-resource settings to lean toward HPV DNA testing, a number of testing platforms have been made available. This study aimed to evaluate the operational parameters of four HPV testing systems in previous ( care HPV) and current (GeneXpert, AmpFire, and MA-6000) use in a secondary healthcare setting in terms of ‘appropriateness’, ease of use, throughput, and diagnostic yield. This descriptive retrospective cohort analysis included 6056 women who presented to our facility between June 2016 and March 2022 for cervical precancer screening via HPV testing. A large majority of this cohort underwent AmpFire testing (55.8%), followed by care HPV (23.3%), MA-6000 (14.7%), and GeneXpert (6.1%). MA-6000 showed the highest hr-HPV positivity rate of 26.4% (95% CI, 23.6–29.5), followed by AmpFire (17.2%; 95% CI, 15.9–17.5). GeneXpert and care HPV showed similar hr-HPV positivity rates of 14.8% (95% CI, 11.3–18.8) and 14.8% (95% CI, 13.0–16.8), respectively. For the AmpFire and MA-6000 platforms, which utilize similar detection and reporting formats, we found a significant excess detection rate of 9.2% (95% CI, 6.1–12.4; p -value

Autor:innen und Institutionen

  • Catholic Hospital, Battor, via Sogakope, Volta Region, Ghana.
  • Faculty of Medicine, School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada.
  • Faculty of Medicine and Dentistry, Department of Emergency Medicine, College of Health Sciences, University of Alberta, Edmonton, AB, Canada.
  • Department of Pathology, University of Cape Coast, School of Medical Sciences, Clinical Teaching Center, Cape Coast, Ghana.

ORCID-Profile: Kofi Effah, Nana Owusu M Essel, Seyram Kemawor

Zitieren

APA

Effah, K., Wormenor, C. M., Tekpor, E., Amuah, J. E., Essel, N. O. M., Gedzah, I., Kemawor, S., Hansen, B. T., Atuguba, B. H., Klutsey, G. B., Sesenu, E., Danyo, S., & Akakpo, P. K. (2023). Evaluating operational parameters of the careHPV, GeneXpert, AmpFire, and MA-6000 HPV systems for cervical precancer screening: Experience from Battor, Ghana. PLOS Global Public Health, 3(8), e0001639. https://doi.org/10.1371/journal.pgph.0001639

Vancouver

Effah K, Wormenor CM, Tekpor E, Amuah JE, Essel NOM, Gedzah I, et al. Evaluating operational parameters of the careHPV, GeneXpert, AmpFire, and MA-6000 HPV systems for cervical precancer screening: Experience from Battor, Ghana. PLOS Global Public Health. 2023;3(8):e0001639. doi:10.1371/journal.pgph.0001639

BibTeX
@article{Effah2023,
  author = {Effah, Kofi and Wormenor, Comfort Mawusi and Tekpor, Ethel and Amuah, Joseph Emmanuel and Essel, Nana Owusu M and Gedzah, Isaac and Kemawor, Seyram and Hansen, Benjamin Tetteh and Atuguba, Bernard Hayford and Klutsey, Gifty Belinda and Sesenu, Edna and Danyo, Stephen and Akakpo, Patrick Kafui},
  title = {Evaluating operational parameters of the careHPV, GeneXpert, AmpFire, and MA-6000 HPV systems for cervical precancer screening: Experience from Battor, Ghana},
  journal = {PLOS Global Public Health},
  year = {2023},
  volume = {3},
  number = {8},
  pages = {e0001639},
  doi = {10.1371/journal.pgph.0001639}
}
Kostenlos starten →